Press Release: Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Dow JonesJan 10 19:00

Bernstein Adjusts Price Target on Insulet to $315 From $305, Keeps Outperform Rating

MT NewswiresJan 9 19:21 · Ratings

Bernstein Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $315

Futu NewsJan 9 07:32 · Ratings

Bernstein Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $305

Futu NewsJan 8 20:34 · Ratings

Diabetes Device Maker Beta Bionics Files for $100M IPO

Seeking AlphaJan 8 05:44

Citi Says 'Buy' These Stocks in '25; SA Quant Ratings Says Maybe Not

Seeking AlphaJan 8 00:17